Literature DB >> 24037299

Evaluation of conventional, dynamic contrast enhanced and diffusion weighted MRI for quantitative Crohn's disease assessment with histopathology of surgical specimens.

Jeroen A W Tielbeek1, Manon L W Ziech, Zhang Li, Cristina Lavini, Shandra Bipat, Willem A Bemelman, Joris J T H Roelofs, Cyriel Y Ponsioen, Frans M Vos, Jaap Stoker.   

Abstract

OBJECTIVES: To prospectively compare conventional MRI sequences, dynamic contrast enhanced (DCE) MRI and diffusion weighted imaging (DWI) with histopathology of surgical specimens in Crohn's disease.
METHODS: 3-T MR enterography was performed in consecutive Crohn's disease patients scheduled for surgery within 4 weeks. One to four sections of interest per patient were chosen for analysis. Evaluated parameters included mural thickness, T1 ratio, T2 ratio; on DCE-MRI maximum enhancement (ME), initial slope of increase (ISI), time-to-peak (TTP); and on DWI apparent diffusion coefficient (ADC). These were compared with location-matched histopathological grading of inflammation (AIS) and fibrosis (FS) using Spearman correlation, Kruskal-Wallis and Chi-squared tests.
RESULTS: Twenty patients (mean age 38 years, 12 female) were included and 50 sections (35 terminal ileum, 11 ascending colon, 2 transverse colon, 2 descending colon) were matched to AIS and FS. Mural thickness, T1 ratio, T2 ratio, ME and ISI correlated significantly with AIS, with moderate correlation (r = 0.634, 0.392, 0.485, 0.509, 0.525, respectively; all P < 0.05). Mural thickness, T1 ratio, T2 ratio, ME, ISI and ADC correlated significantly with FS (all P < 0.05).
CONCLUSIONS: Quantitative parameters from conventional, DCE-MRI and DWI sequences correlate with histopathological scores of surgical specimens. DCE-MRI and DWI parameters provide additional information. KEY POINTS: • Conventional MR enterography can be used to assess Crohn's disease activity. • Several MRI parameters correlate with inflammation and fibrosis scores from histopathology. • Dynamic contrast enhanced imaging and diffusion weighted imaging give additional information. • Quantitative MRI parameters can be used as biomarkers to evaluate Crohn's disease activity.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24037299     DOI: 10.1007/s00330-013-3015-7

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  31 in total

1.  The relationship between inflammatory and serosal connective tissue changes in ileal Crohn's disease: evidence for a possible causative link.

Authors:  N R Borley; N J Mortensen; D P Jewell; B F Warren
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

Review 2.  Correlation and simple linear regression.

Authors:  Kelly H Zou; Kemal Tuncali; Stuart G Silverman
Journal:  Radiology       Date:  2003-06       Impact factor: 11.105

Review 3.  Assessment of wall inflammation and fibrosis in Crohn's disease: value of T1-weighted gadolinium-enhanced MR imaging.

Authors:  Jesica Makanyanga; Shonit Punwani; Stuart A Taylor
Journal:  Abdom Imaging       Date:  2012-12

4.  Diffusion-weighted magnetic resonance without bowel preparation for detecting colonic inflammation in inflammatory bowel disease.

Authors:  Abderrahim Oussalah; Valérie Laurent; Olivier Bruot; Aude Bressenot; Marc-André Bigard; Denis Régent; Laurent Peyrin-Biroulet
Journal:  Gut       Date:  2010-06-04       Impact factor: 23.059

5.  Dynamic contrast enhanced magnetic resonance imaging of the terminal ileum: differentiation of activity of Crohn's disease.

Authors:  Riccardo Del Vescovo; Ilaria Sansoni; Renato Caviglia; Mentore Ribolsi; Giuseppe Perrone; Emanuele Leoncini; Rosario Francesco Grasso; Michele Cicala; Bruno Beomonte Zobel
Journal:  Abdom Imaging       Date:  2008 Jul-Aug

6.  Imaging techniques for assessment of inflammatory bowel disease: joint ECCO and ESGAR evidence-based consensus guidelines.

Authors:  J Panes; Y Bouhnik; W Reinisch; J Stoker; S A Taylor; D C Baumgart; S Danese; S Halligan; B Marincek; C Matos; L Peyrin-Biroulet; J Rimola; G Rogler; G van Assche; S Ardizzone; A Ba-Ssalamah; M A Bali; D Bellini; L Biancone; F Castiglione; R Ehehalt; R Grassi; T Kucharzik; F Maccioni; G Maconi; F Magro; J Martín-Comín; G Morana; D Pendsé; S Sebastian; A Signore; D Tolan; J A Tielbeek; D Weishaupt; B Wiarda; A Laghi
Journal:  J Crohns Colitis       Date:  2013-04-11       Impact factor: 9.071

7.  Non-perforating small bowel Crohn's disease assessed by MRI enterography: derivation and histopathological validation of an MR-based activity index.

Authors:  Michael J Steward; Shonit Punwani; Ian Proctor; Yvette Adjei-Gyamfi; Fiona Chatterjee; Stuart Bloom; Marco Novelli; Steve Halligan; Manuel Rodriguez-Justo; Stuart A Taylor
Journal:  Eur J Radiol       Date:  2011-09-15       Impact factor: 3.528

8.  Evaluation of diffusion-weighted MR imaging for detection of bowel inflammation in patients with Crohn's disease.

Authors:  Aytekin Oto; Fang Zhu; Kirti Kulkarni; Gregory S Karczmar; Jerrold R Turner; David Rubin
Journal:  Acad Radiol       Date:  2009-03-17       Impact factor: 3.173

9.  Mural inflammation in Crohn disease: location-matched histologic validation of MR imaging features.

Authors:  Shonit Punwani; Manuel Rodriguez-Justo; Alan Bainbridge; Rebecca Greenhalgh; Enrico De Vita; Stuart Bloom; Richard Cohen; Alastair Windsor; Austin Obichere; Anika Hansmann; Marco Novelli; Steve Halligan; Stuart A Taylor
Journal:  Radiology       Date:  2009-07-27       Impact factor: 11.105

10.  Grading Crohn disease activity with MRI: interobserver variability of MRI features, MRI scoring of severity, and correlation with Crohn disease endoscopic index of severity.

Authors:  Jeroen A W Tielbeek; Jesica C Makanyanga; Shandra Bipat; Doug A Pendsé; C Yung Nio; Frans M Vos; Stuart A Taylor; Jaap Stoker
Journal:  AJR Am J Roentgenol       Date:  2013-12       Impact factor: 3.959

View more
  52 in total

Review 1.  Assessment of stricturing Crohn's disease: Current clinical practice and future avenues.

Authors:  Dominik Bettenworth; Tobias M Nowacki; Friederike Cordes; Boris Buerke; Frank Lenze
Journal:  World J Gastroenterol       Date:  2016-01-21       Impact factor: 5.742

2.  Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.

Authors:  Peter D R Higgins; Joel G Fletcher
Journal:  Am J Gastroenterol       Date:  2015-03       Impact factor: 10.864

3.  Diffusion-weighted MR enterography for evaluating Crohn's disease: Effect of anti-peristaltic agent on the diagnosis of bowel inflammation.

Authors:  So Hyun Park; Jimi Huh; Seong Ho Park; Seung Soo Lee; Ah Young Kim; Suk-Kyun Yang
Journal:  Eur Radiol       Date:  2016-10-05       Impact factor: 5.315

4.  Preoperative evaluation of small bowel complications in Crohn's disease: comparison of diffusion-weighted and contrast-enhanced MR imaging.

Authors:  M Barat; C Hoeffel; M Bouquot; A S Jannot; R Dautry; M Boudiaf; K Pautrat; R Kaci; M Camus; C Eveno; M Pocard; P Soyer; A Dohan
Journal:  Eur Radiol       Date:  2018-10-09       Impact factor: 5.315

5.  Ability of DWI to characterize bowel fibrosis depends on the degree of bowel inflammation.

Authors:  Xue-Hua Li; Ren Mao; Si-Yun Huang; Zhuang-Nian Fang; Bao-Lan Lu; Jin-Jiang Lin; Shan-Shan Xiong; Min-Hu Chen; Zi-Ping Li; Can-Hui Sun; Shi-Ting Feng
Journal:  Eur Radiol       Date:  2019-01-11       Impact factor: 5.315

6.  Training readers to improve their accuracy in grading Crohn's disease activity on MRI.

Authors:  Jeroen A W Tielbeek; Shandra Bipat; Thierry N Boellaard; C Yung Nio; Jaap Stoker
Journal:  Eur Radiol       Date:  2014-02-22       Impact factor: 5.315

7.  Assessment of normal jejunum with diffusion-weighted imaging on MRE in children.

Authors:  Jordan B Rapp; Sudha A Anupindi; Carolina L Maya; David M Biko
Journal:  Pediatr Radiol       Date:  2018-07-31

8.  Characterization of inflammation and fibrosis in Crohn's disease lesions by magnetic resonance imaging.

Authors:  Jordi Rimola; Núria Planell; Sonia Rodríguez; Salvadora Delgado; Ingrid Ordás; Anna Ramírez-Morros; Carmen Ayuso; Montse Aceituno; Elena Ricart; Aranzazu Jauregui-Amezaga; Julián Panés; Míriam Cuatrecasas
Journal:  Am J Gastroenterol       Date:  2015-01-27       Impact factor: 10.864

9.  Assessment of patency capsule retention using MR diffusion-weighted imaging.

Authors:  Eyal Klang; Uri Kopylov; Shomron Ben-Horin; Adi Lahat; Doron Yablecovitch; Noa Rozendorn; Rami Eliakim; Michal Marianne Amitai
Journal:  Eur Radiol       Date:  2017-07-04       Impact factor: 5.315

Review 10.  Preventing Collateral Damage in Crohn's Disease: The Lémann Index.

Authors:  Gionata Fiorino; Cristiana Bonifacio; Laurent Peyrin-Biroulet; Silvio Danese
Journal:  J Crohns Colitis       Date:  2016-01-07       Impact factor: 9.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.